Literature DB >> 24873728

Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats.

Xiaofei Wang1, Xiao-Ming Xu2.   

Abstract

Schwann cells (SCs) have been considered to be one of the most promising cell types for transplantation to treat spinal cord injury (SCI) due to their unique growth-promoting properties. Despite the extensive use as donor cells for transplantation in SCI models, the fate of SCs is controversial due in part to the lack of a reliable marker for tracing the grafted SCs. To precisely assess the fate and temporal profile of transplanted SCs, we isolated purified SCs from sciatic nerves of adult transgenic rats overexpressing GFP (SCs-GFP). SCs-GFP were directly injected into the epicenter of a moderate contusive SCI at the mid-thoracic level at 1week post-injury. The number of SCs-GFP or SCs-GFP labeled with Bromodeoxyuridine (BrdU) was quantified at 5min, 1day, and 1, 2, 4, 12 and 24weeks after cell injection. Basso, Beattie, and Bresnahan (BBB) locomotor rating scale, footfall error, thermal withdrawal latency, and footprint analysis were performed before and after the SCs-GFP transplantation. After transplantation, SCs-GFP quickly filled the lesion cavity. A remarkable survival of grafted SCs-GFP up to 24weeks post-grafting was observed with clearly identified SC individuals. SCs-GFP proliferated after injection, peaked at 2weeks (26% of total SCs-GFP), decreased thereafter, and ceased at 12weeks post-grafting. Although grafted SCs-GFP were mainly confined within the border of surrounding host tissue, they migrated along the central canal for up to 5.0mm at 4weeks post-grafting. Within the lesion site, grafted SCs-GFP myelinated regenerated axons and expressed protein zero (P0) and myelin basic protein (MBP). Within the SCs-GFP grafts, new blood vessels were formed. Except for a significant decrease of angle of rotation in the footprint analysis, we did not observe significant behavioral improvements in BBB locomotor rating scale, thermal withdrawal latency, or footfall errors, compared to the control animals that received no SCs-GFP. We conclude that SCs-GFP can survive remarkably well, proliferate, migrate along the central canal, and myelinate regenerated axons when being grafted into a clinically-relevant contusive SCI in adult rats. Combinatorial strategies, however, are essential to achieve a more meaningful functional regeneration of which SCs may play a significant role.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional recovery; Migration; Myelination; Proliferation; Schwann cells; Spinal cord injury; Survival

Mesh:

Substances:

Year:  2014        PMID: 24873728      PMCID: PMC4205953          DOI: 10.1016/j.expneurol.2014.05.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  49 in total

Review 1.  Schwann cell transplantation for repair of the adult spinal cord.

Authors:  Martin Oudega; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2006 Mar-Apr       Impact factor: 5.269

Review 2.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

3.  Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord.

Authors:  Caitlin E Hill; Andres Hurtado; Bas Blits; Ben A Bahr; Patrick M Wood; Mary Bartlett Bunge; Martin Oudega
Journal:  Eur J Neurosci       Date:  2007-09       Impact factor: 3.386

4.  Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury.

Authors:  Yu-Hai Ma; Yong Zhang; Li Cao; Jia-Can Su; Zhi-Wei Wang; A-Bing Xu; Shao-Cheng Zhang
Journal:  Cell Transplant       Date:  2010-03-26       Impact factor: 4.064

Review 5.  Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury.

Authors:  Xiao-Ming Xu; Stephen M Onifer
Journal:  Respir Physiol Neurobiol       Date:  2009-08-07       Impact factor: 1.931

Review 6.  Therapeutic interventions after spinal cord injury.

Authors:  Sandrine Thuret; Lawrence D F Moon; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

7.  Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.

Authors:  Caitlin E Hill; Lawrence D F Moon; Patrick M Wood; Mary Bartlett Bunge
Journal:  Glia       Date:  2006-02       Impact factor: 7.452

8.  Repulsive Wnt signaling inhibits axon regeneration after CNS injury.

Authors:  Yaobo Liu; Xiaofei Wang; Chin-Chun Lu; Rachel Kerman; Oswald Steward; Xiao-Ming Xu; Yimin Zou
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

9.  Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus.

Authors:  Shang-Hsun Yang; Yuksel Agca; Pei-Hsun Cheng; Jin-Jing Yang; Cansu Agca; Anthony Wing Sang Chan
Journal:  Genesis       Date:  2007-04       Impact factor: 2.487

Review 10.  Spinal cord repair strategies: why do they work?

Authors:  Elizabeth J Bradbury; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

View more
  9 in total

Review 1.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

2.  Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury.

Authors:  Chandler L Walker; Xiaofei Wang; Carli Bullis; Nai-Kui Liu; Qingbo Lu; Colin Fry; Lingxiao Deng; Xiao-Ming Xu
Journal:  Exp Neurol       Date:  2014-12-12       Impact factor: 5.330

Review 3.  Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury.

Authors:  Shushi Kabu; Yue Gao; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2015-09-04       Impact factor: 9.776

4.  A fibrin matrix promotes the differentiation of EMSCs isolated from nasal respiratory mucosa to myelinating phenotypical Schwann-like cells.

Authors:  Qian Chen; Zhijian Zhang; Jinbo Liu; Qinghua He; Yuepeng Zhou; Genbao Shao; Xianglan Sun; Xudong Cao; Aihua Gong; Ping Jiang
Journal:  Mol Cells       Date:  2015-02-04       Impact factor: 5.034

5.  Low-pressure micro-mechanical re-adaptation device sustainably and effectively improves locomotor recovery from complete spinal cord injury.

Authors:  Veronica Estrada; Julia Krebbers; Christian Voss; Nicole Brazda; Heinrich Blazyca; Jennifer Illgen; Klaus Seide; Christian Jürgens; Jörg Müller; Rudolf Martini; Hoc Khiem Trieu; Hans Werner Müller
Journal:  Commun Biol       Date:  2018-11-26

Review 6.  Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?

Authors:  Civia Z Chen; Björn Neumann; Sarah Förster; Robin J M Franklin
Journal:  Open Biol       Date:  2021-01-27       Impact factor: 6.411

Review 7.  Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.

Authors:  Anastasiia O Sosnovtseva; Olga V Stepanova; Aleksei A Stepanenko; Anastasia D Voronova; Andrey V Chadin; Marat P Valikhov; Vladimir P Chekhonin
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 8.  Repair of the Injured Spinal Cord by Schwann Cell Transplantation.

Authors:  Haitao Fu; Die Hu; Jinli Chen; Qizun Wang; Yingze Zhang; Chao Qi; Tengbo Yu
Journal:  Front Neurosci       Date:  2022-02-17       Impact factor: 4.677

Review 9.  Human Schwann Cell Transplantation for Spinal Cord Injury: Prospects and Challenges in Translational Medicine.

Authors:  Paula V Monje; Lingxiao Deng; Xiao-Ming Xu
Journal:  Front Cell Neurosci       Date:  2021-06-18       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.